Reply
Wed 14 Jul, 2010 10:52 pm
Context:
Minutes before the final vote on Avandia, the FDA's director for new drugs emphasized the high bar needed to pull a previously approved drug from the market.
"The two that have been withdrawn for cardiovascular concerns — Vioxx and Zelnorm — showed three, four or five fold-increase," said John Jenkins "That's the background of where we stand in terms of increased risk of very rare events."
high bar = high standard for what they are going to do
They would not pull (withdraw) an approved medicine if they did not have a lot of evidence.
@oristarA,
It's an analogy with a high jumper, jumping over a bar set very high.